Literature DB >> 16167925

Myocardial infarction and mortality caused by methylergonovine.

Yu-Hung Lin1, Kok-Min Seow, Jiann-Loung Hwang, Huang-Hui Chen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167925     DOI: 10.1111/j.0001-6349.2005.0058d.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


× No keyword cloud information.
  7 in total

1.  Cardiac arrest with pulmonary edema in a non-parturient after ergonovine administration recovered with extracorporeal membrane oxygenation -A case report-.

Authors:  Han Sook Lee; Ji Young Min; Yoonki Lee
Journal:  Korean J Anesthesiol       Date:  2012-12-14

2.  Methylergonovine maleate and the risk of myocardial ischemia and infarction.

Authors:  Brian T Bateman; Krista F Huybrechts; Sonia Hernandez-Diaz; Jun Liu; Jeffrey L Ecker; Jerry Avorn
Journal:  Am J Obstet Gynecol       Date:  2013-07-11       Impact factor: 8.661

Review 3.  Acute myocardial infarction in pregnancy: Current diagnosis and management approaches.

Authors:  Mohan M Edupuganti; Vyjayanthi Ganga
Journal:  Indian Heart J       Date:  2019-12-17

4.  Methylergometrine-Induced Myocardial Infarction in the Setting of a Cesarean Delivery.

Authors:  Mohamed Fayed; Branden Buffington; Rowaa Ibrahim; Ami Y Attali; Joshua Younger
Journal:  Cureus       Date:  2021-12-01

Review 5.  Obstetric Anesthesia and Heart Disease: Practical Clinical Considerations.

Authors:  Marie-Louise Meng; Katherine W Arendt
Journal:  Anesthesiology       Date:  2021-07-01       Impact factor: 8.986

Review 6.  Diagnostic Angiograms and Percutaneous Coronary Interventions in Pregnancy.

Authors:  Phyo Htet Khaing; Gill Louise Buchanan; Vijay Kunadian
Journal:  Interv Cardiol       Date:  2020-05-27

7.  Ergometrine for postpartum hemorrhage and associated myocardial ischemia: Two case reports and a review of the literature.

Authors:  Stuart P E Spencer; Sandra A Lowe
Journal:  Clin Case Rep       Date:  2019-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.